Oorsprong van het eerstegraads netwerk van Steffen Aulwurm
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
SYNIMMUNE GmbH
 SYNIMMUNE GmbH Miscellaneous Commercial ServicesCommercial Services Part of VERAXA Biotech GmbH, SYNIMMUNE GmbH is a biotechnology company based in Tuebingen, Germany. The German company is dedicated to developing innovative and effective mono- and bispecific anti-tumor antibodies for the treatment of patients suffering from life-threatening diseases, with a focus on orphan hematopoietic malignancies. SYNIMMUNE's lead product candidate is the flt3 specific antibody flysyn, which was recently tested in a first-in-human phase i/ii clinical study in aml patients. The CEOs are Ludger Große-Hovest, Martin Steiner. SYNIMMUNE GmbH was founded in 2010 by Gundram Jung, Hans-Georg Rammensee, Ludger Große-Hovest, Steffen Aulwurm, Andreas Herrmann. SYNIMMUNE was acquired by VERAXA Biotech GmbH on December 29, 2023 for $35.54 million.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Steffen Aulwurm via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
ImVision Therapeutics, Inc.
 ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImVision Therapeutics, Inc. develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. The company was founded on January 28, 2005 and is headquartered in Hanover, Germany. | Pharmaceuticals: Major | President | |
| University of Michigan | College/University | Masters Business Admin | |
| University of Vienna | College/University | Doctorate Degree | |
| Apovia AG | President | ||
Alvotech Germany GmbH
 Alvotech Germany GmbH BiotechnologyHealth Technology Baliopharm GmbH operates as biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer. The company was founded in 2011 and is headquartered in Juelich, Germany. | Biotechnology | Chief Executive Officer | |
3Z ehf
 3Z ehf Investment ManagersFinance 3Z ehf engages in the provision of pharmaceuticals services. Its services include epilepsy, sleep, tailor made screening, acute toxicity, cardiovascular, and neurotox assays. The company was founded in by Karl Karlsson and Haraldur Þorsteinsson in 2008 and Is headquartered in Reykjavík, Iceland. | Investment Managers | Director/Board Member | |
Baliopharm AG
 Baliopharm AG Miscellaneous Commercial ServicesCommercial Services Baliopharm AG operates as a biotechnology company. It develops a novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, psoriasis and multiple sclerosis and for cancer. The company was founded in 2011 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistieken
Internationaal
| Duitsland | 5 |
| Zwitserland | 3 |
| Verenigde Staten | 2 |
| Oostenrijk | 2 |
| België | 2 |
Sectoraal
| Commercial Services | 4 |
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Operationeel
| Chief Executive Officer | 6 |
| Founder | 5 |
| Director/Board Member | 4 |
| Director of Finance/CFO | 2 |
| President | 2 |
Sterkste connecties
- Beurs
- Insiders
- Steffen Aulwurm
- Bedrijfsconnecties
